Cargando…

Molecular heterogeneity of breast cancer: implications for treatment and clinical trial design

Detalles Bibliográficos
Autor principal: Pusztai, L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284868/
http://dx.doi.org/10.1186/bcr2265
_version_ 1782351480821383168
author Pusztai, L
author_facet Pusztai, L
author_sort Pusztai, L
collection PubMed
description
format Online
Article
Text
id pubmed-4284868
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42848682015-01-15 Molecular heterogeneity of breast cancer: implications for treatment and clinical trial design Pusztai, L Breast Cancer Res Oral Presentation BioMed Central 2009 2009-06-23 /pmc/articles/PMC4284868/ http://dx.doi.org/10.1186/bcr2265 Text en Copyright © 2009 BioMed Central Ltd.
spellingShingle Oral Presentation
Pusztai, L
Molecular heterogeneity of breast cancer: implications for treatment and clinical trial design
title Molecular heterogeneity of breast cancer: implications for treatment and clinical trial design
title_full Molecular heterogeneity of breast cancer: implications for treatment and clinical trial design
title_fullStr Molecular heterogeneity of breast cancer: implications for treatment and clinical trial design
title_full_unstemmed Molecular heterogeneity of breast cancer: implications for treatment and clinical trial design
title_short Molecular heterogeneity of breast cancer: implications for treatment and clinical trial design
title_sort molecular heterogeneity of breast cancer: implications for treatment and clinical trial design
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284868/
http://dx.doi.org/10.1186/bcr2265
work_keys_str_mv AT pusztail molecularheterogeneityofbreastcancerimplicationsfortreatmentandclinicaltrialdesign